AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015
Mar 5, 2015
30583_dirs_2015-03-05_c567a2e1-87e8-44ee-916b-f27093d0366b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-06-04
Reporting Person: Mueller Brian (VP, Corporate Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-04 | Common Stock | A | 4000 | — | Acquired | 8800 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-04 | Stock Option (right to buy) Common Stock | $63.10 | A | 10000 | Acquired | 2024-06-03 | Common Stock (10000) | Direct |
Footnotes
F1: The transaction is being reported on a delinquent basis due to an administrative oversight.
F2: Restricted stock units granted on June 4, 2014. Price not applicable.
F3: Option grant vests 6/48ths on December 4, 2014, and 1/48th on the 4th of every month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19